Imatinib for Group 1 PAH
Oksana A. Shlobin, MD
PeerSudarshan Rajagopal, MD, PhD
PeerOksana A. Shlobin, MD
PeerIoana Preston, MD
PeerSudarshan Rajagopal, MD, PhD
PeerRichard Krasuski, MD
PeerCTD-PAH: What Is the Focus in 2023?
Vallerie V. McLaughlin, MD
PeerRichard Krasuski, MD
PeerVallerie V. McLaughlin, MD
PeerDinesh Khanna, MD, MS
Peer